Phase Ia trial of a polynucleotide anti-tumor immunization to human carcinoembryonic antigen in patients with metastatic colorectal cancer. Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama

Hum Gene Ther. 1996 Apr 10;7(6):755-72. doi: 10.1089/hum.1996.7.6-755.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I

MeSH terms

  • Adenocarcinoma / secondary
  • Adenocarcinoma / therapy*
  • Animals
  • Cancer Vaccines / adverse effects
  • Cancer Vaccines / genetics
  • Cancer Vaccines / immunology
  • Cancer Vaccines / therapeutic use*
  • Carcinoembryonic Antigen / adverse effects
  • Carcinoembryonic Antigen / genetics
  • Carcinoembryonic Antigen / immunology
  • Carcinoembryonic Antigen / therapeutic use*
  • Clinical Protocols
  • Colorectal Neoplasms / therapy*
  • Hepatitis B Surface Antigens / adverse effects
  • Hepatitis B Surface Antigens / genetics
  • Hepatitis B Surface Antigens / immunology
  • Hepatitis B Surface Antigens / therapeutic use
  • Humans
  • Plasmids
  • Vaccination

Substances

  • Cancer Vaccines
  • Carcinoembryonic Antigen
  • Hepatitis B Surface Antigens